We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.61B
AUM Growth
+$416M
Cap. Flow
+$124M
Cap. Flow %
1.62%
Top 10 Hldgs %
34.83%
Holding
318
New
52
Increased
54
Reduced
160
Closed
42

Top Buys

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$106M
2
SAGE
Sage Therapeutics
SAGE
+$59.7M
3
ILMN icon
Illumina
ILMN
+$59.2M
4
SHOP icon
Shopify
SHOP
+$48.8M
5
AAL icon
American Airlines Group
AAL
+$45.9M

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Consumer Discretionary 18.02%
3 Technology 17.51%
4 Communication Services 15.44%
5 Miscellaneous 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
226
Skyworks Solutions
SWKS
$13.5B
$560K 0.01%
+5,384
New +$545K
ALGN icon
227
Align Technology
ALGN
$10.4B
$557K 0.01%
8,888
+98
+1% +$5.79K
ZLTQ
228
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$549K 0.01%
18,644
-68
-0.4% -$2.05K
CSII
229
DELISTED
Cardiovascular Systems, Inc.
CSII
$501K 0.01%
18,940
-40
-0.2% -$1.29K
PRTA icon
230
Prothena Corp
PRTA
$428M
$491K 0.01%
+9,321
New +$368K
TXTR
231
DELISTED
TEXTURA CORPORATION COM
TXTR
$441K 0.01%
15,844
-114,871
-88% -$3.27M
RARE icon
232
Ultragenyx Pharmaceutical
RARE
$1.29B
$434K 0.01%
4,235
-2,927
-41% -$227K
BIIB icon
233
Biogen
BIIB
$31.9B
$429K 0.01%
1,062
-2
-0.2% -$803
TCRT icon
234
Alaunos Therapeutics
TCRT
$3.58M
$420K 0.01%
+233
New +$362K
VSLR
235
DELISTED
VIVINT SOLAR, INC.
VSLR
$409K 0.01%
33,643
-23,698
-41% -$326K
PODD icon
236
Insulet
PODD
$9.66B
$404K 0.01%
13,036
-1,117,454
-99% -$32.9M
CRDF icon
237
Cardiff Oncology
CRDF
$104M
$384K 0.01%
+526
New +$373K
ATHN
238
DELISTED
Athenahealth, Inc.
ATHN
$356K ﹤0.01%
3,104
-27,637
-90% -$3.3M
CHTR icon
239
Charter Communications
CHTR
$16.8B
$324K ﹤0.01%
1,891
-57,871
-97% -$10.4M
GILD icon
240
Gilead Sciences
GILD
$181B
$323K ﹤0.01%
2,759
+2,421
+716% +$265K
FIT
241
DELISTED
Fitbit, Inc. Class A common stock
FIT
$307K ﹤0.01%
+8,027
New +$282K
LNG icon
242
Cheniere Energy
LNG
$56B
$284K ﹤0.01%
4,094
-45
-1% -$3.37K
CRTO icon
243
Criteo S.A.
CRTO
$837M
$281K ﹤0.01%
5,901
+2,713
+85% +$124K
SRPT icon
244
Sarepta Therapeutics
SRPT
$2.19B
$254K ﹤0.01%
8,339
-8,820
-51% -$180K
EHIC
245
DELISTED
eHi Car Services Limited
EHIC
$249K ﹤0.01%
+17,219
New +$228K
ZTS icon
246
Zoetis
ZTS
$30.3B
$237K ﹤0.01%
4,905
+421
+9% +$20.1K
VECO icon
247
Veeco
VECO
$2.5B
$154K ﹤0.01%
5,373
JUNO
248
DELISTED
Juno Therapeutics, Inc.
JUNO
$154K ﹤0.01%
2,893
-71,906
-96% -$3.82M
ENOV icon
249
Enovis
ENOV
$1.03B
$130K ﹤0.01%
1,631
-3,996
-71% -$339K
GNCA
250
DELISTED
Genocea Biosciences, Inc.
GNCA
$130K ﹤0.01%
+1,184
New +$110K

Similar funds

Gilder Gagnon Howe & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Gilder Gagnon Howe & Co held 318 positions worth $7.61B, up 5.8% from $7.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2015 filing shows 52 new, 54 increased, 160 reduced and 42 closed positions. Its largest new stake was EPAM Systems: 1,551,458 shares worth $111M. The largest sale was KEURIG GREEN MTN INC, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Gilder Gagnon Howe & Co's largest Q2 2015 buy was EPAM Systems: 1,551,458 shares worth $111M.
  • Gilder Gagnon Howe & Co added most to Illumina in Q2 2015, an estimated $59.2M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2015 reduction was Yelp, cutting an estimated $53.3M.
  • Gilder Gagnon Howe & Co fully exited KEURIG GREEN MTN INC in Q2 2015, selling an estimated $154M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 35% of its $7.61B portfolio in Q2 2015.
  • Gilder Gagnon Howe & Co opened 52 new positions and closed 42 in Q2 2015.
  • Gilder Gagnon Howe & Co's portfolio value rose 5.8% quarter-over-quarter to $7.61B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2015, filed 30 Jul 2015.